You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 13, July 14, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Substance Abuse/ Alcoholism
 •Arrhythmias
 •Adverse Effects
 •Alert me on articles by topic

Synthetic Opioids and QT Prolongation—Reply

Since this article does not have an abstract, we have provided the first 125 words of the full text and any section headings.

In reply

We thank Drs Krantz and Mehler for their comments and for highlighting this important problem. Indeed, we are aware of the arrhythmogenic effects of opioid antagonists, and might also highlight that although the authors' own article1 showing that "very high-dose" methadone can cause torsade de points ventricular tachycardia, the actual dosages reported actually range from 65 to 1000 mg/d. Thus, clinicians should be aware that a range of doses of potentially proarrhythmic drugs may be dangerous in patients predisposed to this complication.

For the interested reader, a constantly updated Web site for QT interval–prolonging drugs may be found at http://www.torsades.org.

Nora Goldschlager, MD; Andrew E. Epstein, MD
for the Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology
San Francisco, Calif

1. Krantz MJ, Lewkowiez L, Hays H, Woodroffe M, Robertson AD, Mehler PS. Torsade de pointes associated with very-high dose methadone. Ann Intern Med. 2002;137:501-504. FREE FULL TEXT

Arch Intern Med. 2003;163:1615.


RELATED ARTICLE

Synthetic Opioids and QT Prolongation
Mori J. Krantz and Phillip S. Mehler
Arch Intern Med. 2003;163(13):1615.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.